Filter by: patients

Meloxicam Treatment Report

Category: Prescription Drugs

false

Sort by: Helpfulness | Most Recent

3 patient evaluations for Meloxicam taken for the purpose of 'Fibromyalgia' with a side effects rating of ModerateModerateModerateModerateModerate

Purposes: Pain, Fibromyalgia, and Inflammation (Started Oct 19, 2011)
Date Dosage Pain Perceived effectiveness Fibromyalgia Perceived effectiveness Inflammation Perceived effectiveness Side Effects Adherence Burden
Dec 12, 2012 15 mg Daily Led_efficacy_3Led_efficacy_3Led_efficacy_3Led_default Led_efficacy_3Led_efficacy_3Led_efficacy_3Led_default Led_efficacy_4Led_efficacy_4Led_efficacy_4Led_efficacy_4 ModerateModerateModerateModerate AlwaysAlwaysAlwaysAlways Not at allNot at allNot at allNot at all
Date
Dec 12, 2012
Advice & Tips
Helps alot with the inflamation
  • Icon_thumb_off 0 helpful marks
Purposes: Fibromyalgia and Inflammation (Started Mar 18, 2011)
Date Dosage Fibromyalgia Perceived effectiveness Inflammation Perceived effectiveness Side Effects Adherence Burden
Dec 12, 2012 7.5 mg Daily Led_efficacy_4Led_efficacy_4Led_efficacy_4Led_efficacy_4Major Led_efficacy_4Led_efficacy_4Led_efficacy_4Led_efficacy_4Major ModerateModerateModerateModerateModerate AlwaysAlwaysAlwaysAlwaysAlways Not at allNot at allNot at allNot at allNot at all
Date
Dec 12, 2012
Advice & Tips
Helps so I can sleep better at night.
  • Icon_thumb_off 0 helpful marks
Purpose: Fibromyalgia (Started Jan 01, 2010)
Date Dosage Perceived effectiveness Side Effects Adherence Burden
Jan 03, 2011 7.5 mg Daily Led_efficacy_1Led_defaultLed_defaultLed_defaultNone ModerateModerateModerateModerateModerate SometimesSometimesSometimesSometimesSometimes Not at allNot at allNot at allNot at allNot at all
Jul 31, 2010 7.5 mg Daily Led_efficacy_3Led_efficacy_3Led_efficacy_3Led_defaultModerate NoneNoneNoneNoneNone AlwaysAlwaysAlwaysAlwaysAlways Not at allNot at allNot at allNot at allNot at all
  • Icon_thumb_off 0 helpful marks

11 additional evaluations for Meloxicam are not currently shared publicly.